Meir Panim implements programs that serve Israel’s neediest populations with respect and dignity. Meir Panim also coordinated care packages for families in the South during the Gaza War.
Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.
The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.
“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.
“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.
“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.
Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.
Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.
Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.
According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.
“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.
About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.
If you don't see your comment after publishing it, refresh the page.
Comments are closed.
The funeral for Chaye Zisel Braun began at midnight Wednesday night.
Al-Shaloudi was the nephew of the former Hamas chief and bombmaker Mohiyedine Sharif.
Arab media describes Hamas vehicular terrorist attack as ‘Palestinian ‘shot dead’ by Israeli police.’
Hundreds of Jewish leaders from around the world who are part of the Jewish Agency for Israel Board of Governor will convene in Ashkelon, one of Hamas favorite targets for rockets and missiles, next week. The Board had been set to meet in Mexico as part of its annual rotation amongst the world’s Jewish communities, […]
With all due respect to the IDF, since when is drug smuggling not linked to terror?
A demonstration by 10,000 in Isfahan for women’s rights has morphed into a protest against Iran’s regime.
Syria says it bombed the jets as they were landing in Aleppo.
The baby that was injured in the suspected terror attack this evening died in the hospital.
The train company’s video of the event in Jerusalem that left 8 people injured.
Haifa-based Elbit Systems won an $88 million from an unnamed Asian country for various projects, most of them for an F-5 aircraft avionics upgrade program and the supply of electro-optic and communications systems, Elbit announced Wednesday. The F-5 fighter jet has been in operation for more than 40 years four decades, and is used by […]
Wouldn’t be a lot easier if fanatic Haredim would simply charter their own planes?
One dead, 8 injured, 2 seriously when a car (purposely?) drove into a group of people waiting for a train in Jerusalem.
Please see this article for the latest update. Updates as soon as available. UPDATE 4, 6:42 p.m. Israel Time: Official word from Superintendent Micky Rosenfeld, Israel Police Foreign Press Spokesman is that nine people were injured by a vehicle which struck people at the light rail station. The shots people heard were ones fired at the […]
An Israeli and an Arab poll results after the war.
3000 years ago, King David probably never imagined cars racing at 240 kilometers per hour through the ancient capital of the Jewish people.
Reuven Rivlin made a festive visit to the northern Israeli town of Kfar Yasif near Acre, in honor of the Muslim Feast of the Sacrifice, Eid al-Adha, which coincided with Yom Kippur this year.
“The meaning of Yom Kippur takes on an added significance when we think of all the rockets that were fired and the people who were saved by miracles this summer.
Israeli police revealed on September 30 that they are now investigating the possibility that a fellow Arab worker may have cut the cable that held Arami as he was doing exterior work on a building.
Immigration to Israel this year was up 28% compared to the previous year. An estimated total of 24,800 new immigrants arrived to Israel throughout the course of the year.
Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/
Scan this QR code to visit this page online: